acknowledge Arjan van den Berg, Margreet de Vries and Marten Engelse for their
technical assistance, and Clemens Löwik for help with the C2C12 cells and VEGF
receptor PCR.
VEGF Upregulates Myoglobin in Ischemic Muscle
149
References
1. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is
a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
2. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, Isner JM. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel
development in patients with critical limb ischemia. Circulation. 1998;97:1114-1123.
3. Hendel RC, Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M, Bonow RO. Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial
perfusion: evidence for a dose-dependent effect. Circulation. 2000;101:118-121.
4. Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient
with ischemic limb. Lancet. 1996;348:370-374.
5. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial
injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 1998;98:2800-2804.
6. Losordo DW, Vale PR, Hendel RC, Milliken CE, Fortuin FD, Cummings N, Schatz RA, Asahara T, Isner JM, Kuntz RE. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic
myocardial ischemia. Circulation. 2002;105:2012-2018.
7. Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, Horowitz JR, Symes JF, Isner JM. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor
augments collateral development and tissue perfusion. Circulation. 1996;94:3281-3290.
8. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease
detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-1324.
9. Wittenberg BA, Wittenberg JB. Transport of oxygen in muscle. Annu Rev Physiol. 1989;51:857-878.
10. Campbell WG, Gordon SE, Carlson CJ, Pattison JS, Hamilton MT, Booth FW. Differential global
gene expression in red and white skeletal muscle. Am J Physiol Cell Physiol. 2001;280:C763-
C768.
11. Steinacker JM, Opitz-Gress A, Baur S, Lormes W, Bolkart K, Sunder-Plassmann L, Liewald F, Lehmann M, Liu Y. Expression of myosin heavy chain isoforms in skeletal muscle of patients with
peripheral arterial occlusive disease. J Vasc Surg. 2000;31:443-449.
12. Godecke A, Flogel U, Zanger K, Ding Z, Hirchenhain J, Decking UK, Schrader J. Disruption of
myoglobin in mice induces multiple compensatory mechanisms. Proc Natl Acad Sci U S A.
1999;96:10495-10500.
13. Lescaudron L, Peltekian E, Fontaine-Perus J, Paulin D, Zampieri M, Garcia L, Parrish E. Blood borne macrophages are essential for the triggering of muscle regeneration following muscle
transplant. Neuromuscul Disord. 1999;9:72-80.
14. Rissanen TT, Vajanto I, Hiltunen MO, Rutanen J, Kettunen MI, Niemi M, Leppanen P, Turunen MP, Markkanen JE, Arve K, Alhava E, Kauppinen RA, Yla-Herttuala S. Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 (KDR/Flk-1) in
Ischemic Skeletal Muscle and Its Regeneration. Am J Pathol. 2002;160:1393-1403.
15. Germani A, Di Carlo A, Mangoni A, Straino S, Giacinti C, Turrini P, Biglioli P, Capogrossi MC.
Vascular endothelial growth factor modulates skeletal myoblast function. Am J Path.
2003;163:1417-28.
16. Quax PH, Lamfers ML, Lardenoye JH, Grimbergen JM, de Vries MR, Slomp J, de Ruiter MC, Kockx MM, Verheijen JH, van Hinsbergh VW. Adenoviral expression of a urokinase receptor-
Chapter 6
150
targeted protease inhibitor inhibits neointima formation in murine and human blood vessels. Circulation. 2001;103:562-569.
17. Fallaux FJ, Kranenburg O, Cramer SJ, Houweling A, Van Ormondt H, Hoeben RC, Van Der Eb AJ. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-
deleted adenoviral vectors. Hum Gene Ther. 1996;7:215-222.
18. Piek JJ, Alvarez TR, Jutzy K, Morales AR, Boucek RJ. Polyacrylamide-bismuth for postmortem
coronary arteriography. Lab Invest. 1982;46:485-488.
19. Cohen M, Rentrop KP. Limitation of myocardial ischemia by collateral circulation during sudden
controlled coronary artery occlusion in human subjects: a prospective study. Circulation.
1986;74:469-476.
20. Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM. Mouse model of
angiogenesis. Am J Pathol. 1998; 152: 1667–1679.
21. Dubowitz V, Brooke MH. Histological and histochemical stains and reactions. In: Dubowitz V
and Brooke MH, eds. Muscle Biopsy: A Modern Approach. London: Saunders; 1973:20-33.
22. Lee-de Groot MBE, Tombe AL, van der Laarse WJ. Calibrated histochemistry of myoglobin
concentration in cardiomyocytes. J Histochem Cytochem. 1998;46:1077-1084.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-
phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
24. Deckers MML, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Löwik CWGM. Expression of vascular endothelial growth factors (VEGFs) and their receptors during osteoblast
differentiation. Endocrinology. 2000;141:1667-1674.
25. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelman BM. Transcriptional co-activator PGC-1 alpha drives the
formation of slow-twitch muscle fibres. Nature. 2002;418:797-801.
26. Deindl E, Buschmann I, Hoefer IE, Podzuweit T, Boengler K, Vogel S, van Royen N, Fernandez B, Schaper W. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery
occlusion in the rabbit. Circ Res. 2001;89:779-786.
27. Lindner V, Maciag T. The putative convergent and divergent natures of angiogenesis and
arteriogenesis. Circ Res. 2001;89:747-749.
28. Mallat Z, Silvestre JS, Le Ricousse-Roussanne S, Lecomte-Raclet L, Corbaz A, Clergue M, Duriez M, Barateau V, Akira S, Tedgui A, Tobelem G, Chvatchko Y, Levy BI. Interleukin-18/interleukin-18
binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb. Circ
Res. 2002;91:441-448.
29. Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, Kholova I, Kauppinen RA, Achen MG, Stacker SA, Alitalo K, Yla-Herttuala S. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via
adenoviruses. Circ Res. 2003;92:1098-1106.
30. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM,
Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med.
2000;6:460-463.
31. Burkholder TJ, Fingado B, Baron S, Lieber RL. Relationship between muscle fiber types and sizes
and muscle architectural properties in the mouse hindlimb. J Morphol. 1994;221:177-190.
32. Grosskreutz CL, Anand-Apte B, Duplaa C, Quinn TP, Terman BI, Zetter B, D'Amore PA. Vascular
endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc
Res. 1999;58:128-136.
33. Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, Gravereaux E, Pieczek A, Iwaguro H, Hayashi SI, Isner JM, Asahara T. Vascular endothelial growth factor(165) gene transfer augments
VEGF Upregulates Myoglobin in Ischemic Muscle
151
34. Schratzberger P, Schratzberger G, Silver M, Curry C, Kearney M, Magner M, Alroy J, Adelman LS, Weinberg DH, Ropper AH, Isner JM. Favorable effect of VEGF gene transfer on ischemic
peripheral neuropathy. Nat Med. 2000;6:405-413.
35. Shen H, Clauss M, Ryan J, Schmidt AM, Tijburg P, Borden L, Connolly D, Stern D, Kao J. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on
mononuclear phagocytes. Blood. 1993;81:2767-2773.
36. Lambrechts D, Storkebaum E, Morimoto M, Del Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, Van M, I, Al Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice
and humans and protects motoneurons against ischemic death. Nat Genet. 2003;34:383-94.
37. Pette D. Historical Perspectives: plasticity of mammalian skeletal muscle. J Appl Physiol.
2001;90:1119-1124.
38. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, Wu H, Zhu W, Bassel- Duby R, Williams RS. A calcineurin-dependent transcriptional pathway controls skeletal muscle
fiber type. Genes Dev. 1998;12:2499-2509.
39. Wu H, Rothermel B, Kanatous S, Rosenberg P, Naya FJ, Shelton JM, Hutcheson KA, DiMaio JM, Olson EN, Bassel-Duby R, Williams RS. Activation of MEF2 by muscle activity is mediated through
a calcineurin-dependent pathway. EMBO J. 2001;20:6414-6423.
40. Armesilla AL, Lorenzo E, Gomez dA, Martinez-Martinez S, Alfranca A, Redondo JM. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a